These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 29625702

  • 1. Comparison of Long-Term Survival Benefits With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Versus Without Diabetes Mellitus (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT]).
    Kutyifa V, Naqvi SY, Brown M, McNitt S, Goldenberg I, Klein H, Moss AJ.
    Am J Cardiol; 2018 Jun 15; 121(12):1567-1574. PubMed ID: 29625702
    [Abstract] [Full Text] [Related]

  • 2. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y, Zareba W, Goldenberg I, Klein H, McNitt S, Polonsky B, Moss AJ, Kutyifa V, MADIT‐CRT Executive Committee.
    J Am Heart Assoc; 2015 Jun 29; 4(7):. PubMed ID: 26124205
    [Abstract] [Full Text] [Related]

  • 3. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
    Martin DT, McNitt S, Nesto RW, Rutter MK, Moss AJ.
    Circ Heart Fail; 2011 May 29; 4(3):332-8. PubMed ID: 21350054
    [Abstract] [Full Text] [Related]

  • 4. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC, Pietrasik G, Goldenberg I, Kutyifa V, Daubert JP, Ruwald MH, Jons C, McNitt S, Wang P, Zareba W, Moss AJ.
    J Am Coll Cardiol; 2014 Apr 01; 63(12):1190-1197. PubMed ID: 24333490
    [Abstract] [Full Text] [Related]

  • 5. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y, Kutyifa V, Cygankiewicz I, Goldenberg I, Klein H, McNitt S, Polonsky B, Ruwald AC, Ruwald MH, Moss AJ, Zareba W.
    Circ Heart Fail; 2016 Feb 01; 9(2):e002667. PubMed ID: 26823498
    [Abstract] [Full Text] [Related]

  • 6. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V, Stockburger M, Daubert JP, Holmqvist F, Olshansky B, Schuger C, Klein H, Goldenberg I, Brenyo A, McNitt S, Merkely B, Zareba W, Moss AJ.
    Circ Arrhythm Electrophysiol; 2014 Aug 01; 7(4):645-51. PubMed ID: 24963007
    [Abstract] [Full Text] [Related]

  • 7. Marital Status and Long-Term Outcomes in Mild Heart Failure Patients With an Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator.
    Goldenberg M, Aktas MK, Younis A, Zareba W, McNitt S, Kutyifa V.
    Am J Cardiol; 2020 Apr 15; 125(8):1180-1186. PubMed ID: 32088000
    [Abstract] [Full Text] [Related]

  • 8. Left Ventricular Lead Location and Long-Term Outcomes in Cardiac Resynchronization Therapy Patients.
    Kutyifa V, Kosztin A, Klein HU, Biton Y, Nagy VK, Solomon SD, McNitt S, Zareba W, Goldenberg I, Roka A, Moss AJ, Merkely B, Singh JP.
    JACC Clin Electrophysiol; 2018 Nov 15; 4(11):1410-1420. PubMed ID: 30466845
    [Abstract] [Full Text] [Related]

  • 9. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A, Kutyifa V, Moss AJ, Mathias A, Barsheshet A, Pouleur AC, Knappe D, McNitt S, Polonsky B, Huang DT, Solomon SD, Zareba W, Goldenberg I.
    Heart Rhythm; 2013 Aug 15; 10(8):1136-43. PubMed ID: 23712031
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS, Ruwald AC, Kutyifa V, Ruwald MH, Mcnitt S, Polonsky B, Goldstein RE, Haigney MC, Krone RJ, Zareba W, Moss AJ, MADIT-CRT Investigators.
    Europace; 2015 Dec 15; 17(12):1816-22. PubMed ID: 26071234
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC, Solomon SD, Bourgoun M, McNitt S, Goldenberg I, Klein H, Moss AJ, Foster E, MADIT-CRT Executive Committee.
    J Am Coll Cardiol; 2012 Jun 19; 59(25):2366-73. PubMed ID: 22698490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.